These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32547006)

  • 1. Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping.
    Zhang X; Wu Z; Liu Y; Jiang S
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1199-1206. PubMed ID: 32547006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of type 2 inflammation on bronchodilator responsiveness of large and small airways in chronic obstructive pulmonary disease].
    Xu G; Gong Z; Wang J; Ma Y; Xu M; Chen M; Hu D; Liang J; Zhao W; Zhao H
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):93-99. PubMed ID: 38293980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fractional exhaled nitric oxide in bronchial inflammatory lung diseases].
    Xia Q; Pan P; Wang Z; Lu R; Hu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 39(4):365-70. PubMed ID: 24820276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 5. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
    Chen FJ; Lin GP; Huang XY; Liu YL; Zeng ZM; Guo YB
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2663-2671. PubMed ID: 31819399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Fractional Exhaled Nitric Oxide in Elderly Patients with Asthma-chronic Obstructive Pulmonary Disease Overlap and Other Airway Inflammatory Diseases.
    Shi F; Qiu C; Yu J; Yang Y; Li B; Feng M; Zhang T; Liu W
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):232-239. PubMed ID: 29908540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of pulmonary function and FeNO detection in early screening of patients with ACO.
    Wang J; Wang W; Lin H; Huan C; Jiang S; Lin D; Cao N; Ren H
    Exp Ther Med; 2020 Aug; 20(2):830-837. PubMed ID: 32742326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of bronchodilator response in FEV1 and FeNO for differentiating between chronic respiratory diseases: an observational study.
    Gong Z; Huang J; Xu G; Chen Y; Xu M; Ma Y; Zhao W; Wang Y; Liang J; Ou C; Liu L; Cai S; Zhao H
    Eur J Med Res; 2024 Feb; 29(1):97. PubMed ID: 38311782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
    Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness.
    Chen C; Jian W; Gao Y; Xie Y; Song Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2519-2526. PubMed ID: 27785008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
    Chhabra SK; Bhatnagar S
    Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
    Fortis S; Quibrera PM; Comellas AP; Bhatt SP; Tashkin DP; Hoffman EA; Criner GJ; Han MK; Barr RG; Arjomandi M; Dransfield MB; Peters SP; Dolezal BA; Kim V; Putcha N; Rennard SI; Paine R; Kanner RE; Curtis JL; Bowler RP; Martinez FJ; Hansel NN; Krishnan JA; Woodruff PG; Barjaktarevic IZ; Couper D; Anderson WH; Cooper CB;
    Chest; 2023 Mar; 163(3):502-514. PubMed ID: 36395858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
    Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
    J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of Fractional Exhaled Nitric Oxide after Using a Beta-2 Bronchodilator in the Differential Diagnosis of Bronchial Asthma and Chronic Obstructive Pulmonary Disease].
    Ura M; Tanaka H; Takahashi K; Yamazaki H; Fujimoto K
    Rinsho Byori; 2016 Feb; 64(2):127-32. PubMed ID: 27311275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of short-term exposure to ambient NO(2) on lung function and fractional exhaled nitric oxide in 33 chronic obstructive pulmonary disease patients].
    Shan J; Ni Y; Dong W; Xu JH; Pan L; Li HY; Yang X; Wu SW; Chen YH; Deng FR; Guo XB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):527-532. PubMed ID: 28592098
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial.
    Parekh TM; Helgeson ES; Connett J; Voelker H; Ling SX; Lazarus SC; Bhatt SP; MacDonald DM; Mkorombindo T; Kunisaki KM; Fortis S; Kaminsky D; Dransfield MT
    Ann Am Thorac Soc; 2022 Oct; 19(10):1642-1649. PubMed ID: 35363600
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.
    Barjaktarevic IZ; Buhr RG; Wang X; Hu S; Couper D; Anderson W; Kanner RE; Paine Iii R; Bhatt SP; Bhakta NR; Arjomandi M; Kaner RJ; Pirozzi CS; Curtis JL; O'Neal WK; Woodruff PG; Han MK; Martinez FJ; Hansel N; Wells JM; Ortega VE; Hoffman EA; Doerschuk CM; Kim V; Dransfield MT; Drummond MB; Bowler R; Criner G; Christenson SA; Ronish B; Peters SP; Krishnan JA; Tashkin DP; Cooper CB;
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2927-2938. PubMed ID: 31908441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.
    Li Y; Lin J; Wang Z; Wang Z; Tan L; Liu S; Huang J; Gao Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2623-2633. PubMed ID: 36274994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
    Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
    BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.